Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 319

1.

Dual blockade of the renin-angiotensin system in diabetic nephropathy.

Wade VL, Gleason BL.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1278-82. Epub 2004 Jun 8. Review.

PMID:
15187210
2.
3.

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.

Parving HH, Andersen S, Jacobsen P, Christensen PK, Rossing K, Hovind P, Rossing P, Tarnow L.

Semin Nephrol. 2004 Mar;24(2):147-57. Review.

PMID:
15017527
4.
5.
6.

The reno-protective effect of the dual blockade of the renin angiotensin system (RAS).

Luno J, Praga M, de Vinuesa SG.

Curr Pharm Des. 2005;11(10):1291-300. Review.

PMID:
15853685
7.

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.

PMID:
16797382
8.

Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.

Schjoedt KJ, Jacobsen P, Rossing K, Boomsma F, Parving HH.

Horm Metab Res. 2005 Apr;37 Suppl 1:4-8.

PMID:
15918104
9.
10.
11.

Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy.

Dalla Vestra M, Simioni N, Masiero A.

Int Urol Nephrol. 2009;41(1):119-26. doi: 10.1007/s11255-008-9490-0. Epub 2008 Oct 29. Review.

PMID:
18958580
12.

Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).

Jacobsen PK.

J Renin Angiotensin Aldosterone Syst. 2005 Sep;6(2):55-68. Review.

PMID:
16470484
13.

Pharmacologic management of diabetic nephropathy.

Vivian EM, Rubinstein GB.

Clin Ther. 2002 Nov;24(11):1741-56; discussion 1719. Review.

PMID:
12501871
14.

Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.

Fernandez-Juárez G, Barrio V, de Vinuesa SG, Goicoechea M, Praga M, Luño J.

J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S250-4. Review.

15.

Can dual blockade of the renin-angiotensin system reduce progression of kidney disease beyond monotherapy?

Brewster UC, Perazella MA.

Expert Opin Drug Saf. 2004 Jan;3(1):9-23. Review.

PMID:
14680458
16.

Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.

Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.

Am J Kidney Dis. 2008 Sep;52(3):475-85. doi: 10.1053/j.ajkd.2008.03.008. Epub 2008 May 12.

PMID:
18468748
17.

Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease.

Andersen NH, Mogensen CE.

Curr Hypertens Rep. 2004 Oct;6(5):369-76. Review.

PMID:
15341690
18.
19.

Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.

Cantarovich F, Rangoonwala B.

Int J Clin Pract. 2003 Nov;57(9):801-22. Review.

PMID:
14686572
20.

ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trial.

Düsing R, Sellers F.

Curr Med Res Opin. 2009 Sep;25(9):2287-301. doi: 10.1185/03007990903152045. Review.

PMID:
19635044

Supplemental Content

Support Center